Overview

A Phase I Study of TRN501 in Healthy Volunteers

Status:
COMPLETED

Trial end date:
2024-09-20

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of TRN501 following a single administration of TRN501 or placebo to healthy adult male volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

SNLD, Ltd.